Matthew Jason Brown, | |
49 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3049 | |
(404) 778-7777 | |
Not Available |
Full Name | Matthew Jason Brown |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 49 Jesse Hill Jr Dr Se, Atlanta, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043714785 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 86939 (Georgia) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Matthew Jason Brown, 49 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3049 Ph: (404) 778-7777 | Matthew Jason Brown, 49 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3049 Ph: (404) 778-7777 |
News Archive
Proscia Inc., a data solutions provider for digital pathology, and Samsung Medical Center, South Korea's preeminent clinical and biomedical research institute, today announced a partnership focused on developing tools that enable predictive medicine in the fight against cancer.
Parents are mostly willing to consent to post mortem research on their children, providing they are approached by specialist nurses, experienced in bereavement and family counselling, suggests a small study published ahead of print in the Archives of Disease in Childhood.
According to the World Health Organization, approximately 37 million people are living with HIV. Antiviral medications are used to control the disease and prevent its progression to AIDS.
A quiet transformation has been brewing in medicine, as large-scale DNA results become increasingly available to patients and healthcare providers.
China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on September 2, 2009, the PRC's State Food and Drug Administration (the "SFDA") renewed SFDA certification of compliance with Good Manufacturing Practices ("GMP") for the production facility of Qianfeng Biological Products Co., Ltd. ("Qianfeng"), China Biologic's indirectly owned subsidiary.
› Verified 2 days ago